Schizophrenia Clinical Trial
Official title:
Joining Forces: Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana
The purpose of this study is to evaluate a bundled intervention of psychotropic drugs and daily contact with a nurse for people with mental health disorders in a prayer camp and secondly to assess whether the attitudes of the prayer camp staff toward mental health disorders and conventional medicines remain the same after the intervention.
The purpose of this study is to evaluate a bundled intervention of psychotropic drugs and
daily contact with a nurse for people with mental health disorders in a prayer camp and
secondly to assess whether the attitudes of the prayer camp staff toward mental health
disorders and conventional medicines remain the same after the intervention.
In the proposed study, residents of the sanatorium at the Mount Horeb Prayer Center located
in Mamfe, Ghana will be screened for psychiatric disorders by a psychiatrist. Those who are
diagnosed with a psychiatric disorder requiring treatment (schizophrenia, or mood disorder)
and who meet the other inclusion criteria (see below) will be randomly assigned to receive a
daily dose of the appropriate psychotropic drug (according to standard procedures of care)
as well as regular prayer camp treatment (intervention group) or to receive only regular
prayer camp treatment (control group). After randomization, the patients in the intervention
group will receive the bundled treatment for 6 weeks, while control group patients will
receive regular prayer camp treatment, e.g. encouragement to pray. Psychiatrists blinded to
group assignments will assess outcomes over a 6 - 8 week period. Following this, patients
will be referred for continued care with health care facilities as close to their homes as
possible on discharge and if they so desire. At the start of the intervention, pastors and
attendants at the prayer camp will be qualitatively assessed through a semi-structured
interview concerning their attributions of mental illness causation. They will be assessed
-0, -6 weeks after and again -12 weeks after intervention. The investigators hypothesize
that patients who receive the bundled intervention will have improved mental health outcomes
and functioning and that prayer camp staff will develop more positive attitudes toward
conventional medicine and will begin to conceptualize mental health disorders as treatable
illnesses, rather than only as a spiritual disorder. The results will provide empirical
evidence for or against an integrated model of community based care which encompasses the
medical and spiritual. This is the first intervention study in Sub-Saharan Africa to promote
the use of psychotropic drugs in a traditional or spiritual healing setting. Its findings
may inform the implementation of national policies governing collaboration between primary
health care and faith healing centers, expanding access to and improving the quality of
mental health care services.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |